Submission of investor complaint for the quarter ended 31.03.2025
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has filed its quarterly investor complaint report with BSE for the three months ending 31 March 2025, as required under SEBI's Listing Regulations. The report shows zero complaints pending at the start of the quarter (1 January 2025), zero complaints received during the quarter, zero complaints disposed of, and zero complaints remaining unresolved at the end of the quarter. The filing was signed by Company Secretary Pooja Chuni on 15 April 2025 and was also shared with the Ahmedabad Stock Exchange.
This is a routine compliance filing showing no investor grievances during the January–March 2025 quarter, which is a neutral-to-slightly-positive signal reflecting clean shareholder servicing with no pending issues.